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were challenged by in vivo collagenase treatment, increased staining of
the chondrocytes was seen.
Conclusions: We identiﬁed a genetic variant on chromosome 19 to be
associated with cartilage thickness and hip OA. The variant is located
in a gene showing an expression pattern that supports a role in
chondrogenetic differentiation. GWAS for underlying endophenotypes
might be a proliﬁc route to identify risk loci for complex diseases
such as OA.
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Purpose: Aberrant transcription proﬁling in osteoarthritis(OA) synovial
ﬁbroblasts(SFs) lacking consistent speciﬁc genetic mutations suggests
that epigenetic mechanisms along with the environmental factors
may be involved in its pathogenesis. Compared to those from
normal or rheumatoid arthritis(RA) SFs, over-activated OASFs have an
important role in the destruction of normal joint architecture, and
the imprinted, phenotypical aggressiveness could be determined by
epigenetic mechanism. To investigate a global DNAmethylation of human
OASFs using methylated DNA isolation assay (MeDIA)-CpG promoter
microarray, and compared it with SFs of RA patients or healthy controls
in Korean population.
Methods: Human synovial tissue samples obtained during undergoing
total knee joint replacement surgery in 2 OA and 3 RA patients. 2
Normal synovium was collected by arthroscopic or open knee surgery
of traumatic ligament injury of healthy populations. Total DNA extracted
from SFs using the QIAamp DNA mini and blood kit protocol (Qiagen,
Hilden, Germany). To discover novel hypo- or hypermethylated genes
in OA by genome-wide search, we introduce a MeDIA-coupled CpG
microarray method for directly identifying differentially methylated
regions of the genomes in each pooled synovial cells between OA and RA
patients. The methylation status of promising candidates was validated
by quantitative pyrosequencing assay in each synovial cells.
Results: In two CpG microarray, 4 genes were screened as 5
fold hypomethylated targets among 1,714 porbes. Through stepwise
subtraction processes, we ﬁnally selected four candidate targets. Among
of these targets, two genes, APEX1 gene(gt-OA1) and TGFB1 gene(gt-OA2)
have shown so far a signiﬁcant decrease in the methylation frequency
in OA when compared in independent groups of synovial DNA samples
from OA patients with from RA and normal controls.
Conclusions: APEX1 and TGFB1 gene promoter is hypomethylated in
OASFs than OA and healthy controls. Pathophysiologic correlation and
their role as a diagnostic or prognostic marker should be investigated in
a larger number of patients group hereafter.
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Purpose: The evidence for an association between mutations in HFE
gene related to hemochromatosis and risk of hip or knee osteoarthritis is
inconsistent. Total joint replacement is considered a surrogate measure
for symptomatic end-stage osteoarthritis. This study aimed to examine
the relationship between HFE gene mutations and risk of total hip and
knee replacement in a population-based cohort.
Methods: The Melbourne Collaborative Cohort Study is a prospective
cohort study that commenced recruitment in 1990. Participants born in
Australia, New Zealand, the United Kingdom, or Ireland (n =27,848) were
genotyped for the HFE C282Y variant. Total hip and knee replacements for
osteoarthritis during 2001–2009 were ascertained from the Australian
Orthopaedic Association National Joint Replacement Registry. Hazard
ratios (HRs) and conﬁdence intervals (CIs) were obtained from Cox
regression.
Results: Compared to those with no C282Y variant, C282Y homozygotes
were at increased risk of total hip replacement (HR 1.94, 95% CI 1.04–
3.62). The association was stronger for men (HR 3.34, 95% CI 1.48–7.52)
than for women (HR 1.22, 95% CI 0.46–3.27) (p for interaction = 0.21).
Only 3 C282Y homozygotes had total knee replacements; the HR was
0.51 (95% CI 0.16–1.57). C282Y/H63D compound heterozygosity was not
related to the risk of total hip or knee replacement.
Conclusions: HFE C282Y homozygosity was associated with increased
risk of total hip replacement for osteoarthritis for men but not for
women. The mechanism for this is unknown and the ﬁndings need to
be conﬁrmed in future studies.
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THE mtDNA HAPLOGROUPS INFLUENCE THE PROGRESSION OF
OSTEOARTHRITIS (OA)
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Purpose: To analyze the inﬂuence of the mtDNA haplogroups in the
progression of the osteoarthritis (OA) disease.
Methods: The DNA of 282 knee and/or hip OA samples from Hospital
Universitario A Corun˜a was isolated to obtain their mtDNA haplogroups.
Knee and/or hip radiographs from all these samples were obtained at
two stages of the OA disease of at least 36 months between them,
and evaluated according to the K/L scale from grade 0 to IV. Statistical
analyses included Kaplan-Meier survival curves for each haplogroup or
cluster tested, as well as Cox regression models taking into account
another variables such as gender, haplogroup (or cluster) and body mass
index (BMI).
Results: For this study, two types of progression were established: OA
progression and severity progression. We considered OA progression
when a patient evolved from K/L grade 0-I to K/L grade II-III or K/L
grade IV, and from K/L grade II-III to K/L grade IV, in at least one of the
joints analyzed. The results obtained showed that the OA progression
varies signiﬁcantly according to the mtDNA haplogroups (p = 0.030),
and the main differences were detected when compared patients that
belonged to the cluster TJ (better progressors) with patients of the
cluster KU (worse progressors) (p = 0.083) (Figure 1). On the other hand,
we considered severity progression when a patient evolved to knee
or hip prosthesis from an initial K/L grade III or less. In this case, the
results obtained showed that patients carrying the most common mtDNA
haplogroup H had a worse severity progression than non-H patients
(p = 0.035) (Figure 2). The Cox regression model also showed that males
evolved worse than females (p = 0.028).
Conclusions: The mtDNA haplogroups inﬂuence the progression of OA;
these results strength the role of the mitochondria in the OA disease.
Fig. 1. Kaplan–Meier survival curve showing the different OA progression
between clusters KU and TJ.
